Friday, December 3, 2021
Advertisement

New Zealand: Vital Healthcare to raise NZ$150m

New Zealand’s Vital Healthcare Property Trust is to raise NZ$150m (US$99m) new equity capital, through a NZ$125m underwritten placement which has completed and a...

New Zealand: Oceania Healthcare sets margin for debt issue

Oceania Healthcare has set the indicative margin for its up to NZ$125m (US$82m) deal at 2.00% to 2.20%. New Zealand’s third-largest residential aged care provider...

Switzerland: Sophia Genetics raises US$110m Series F

Lausanne-based medical data specialists Sophia Genetics has raised US$110m in an oversubscribed round of Series F funding. The round was led by aMoon, a leading...

Global: Early-stage funding weighted towards Asia

This week has seen no slowdown in the capital that is being raised by early-stage healthcare companies, though Asia has seen the volume. In Korea,...

Japan: Nippon Life commits US$100m to healthcare fund

Nippon Life Insurance, Japan’s largest life insurance company, has committed US$100m in Grove Street’s Life Science Impact Program fund, as part of its active...

Hong Kong: Good Doctor raises HK$7.9bn in placement

Ping An Good Doctor (PAGD), China’s biggest online health care platform, has raised HK7.9bn (US$1bn) in a primary share placement in Hong Kong. It sold...

UAE: Alvarez & Marsal appointed administrators of more than 30 NMC businesses

Consultancy firm Alvarez & Marsal have been appointed as administrators of a large number of NMC Health-related companies in the Abu Dhabi Global Market...

Egypt: Speed Medical adds three facilities to portfolio

Egyptian healthcare group Speed Medical Company has signed a deal to manage several medical facilities in Alexandria. Financial terms for the deal have not...

Hong Kong: JD Health files for Hong Kong IPO

In a move that had been widely expected, JD Health, the healthcare unit of JD.com, has filed for its initial public offering in Hong...

Europe: European healthcare companies raise early-stage funding

Over the past week, European healthcare companies have been at the forefront of raising early-stage capital. In the Netherlands, Salvia BioElectronics has raised €26m (US$31m)...